Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENDR1: Autologous Tumor Lysate-Loaded Dendritic Cells in Newly Diagnosed Glioblastoma
NCT04801147Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jun 2010
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in glioblastoma multiforme (GBM), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Progression Free Survival at 12 months. Started Jun 2010; status: completed.
02
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT04801147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801147.